JP2020183439A5 - - Google Patents

Download PDF

Info

Publication number
JP2020183439A5
JP2020183439A5 JP2020127851A JP2020127851A JP2020183439A5 JP 2020183439 A5 JP2020183439 A5 JP 2020183439A5 JP 2020127851 A JP2020127851 A JP 2020127851A JP 2020127851 A JP2020127851 A JP 2020127851A JP 2020183439 A5 JP2020183439 A5 JP 2020183439A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
patient
antibody
composition according
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020127851A
Other languages
English (en)
Japanese (ja)
Other versions
JP7104108B2 (ja
JP2020183439A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2020183439A publication Critical patent/JP2020183439A/ja
Publication of JP2020183439A5 publication Critical patent/JP2020183439A5/ja
Priority to JP2022108732A priority Critical patent/JP7467538B2/ja
Application granted granted Critical
Publication of JP7104108B2 publication Critical patent/JP7104108B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020127851A 2014-07-16 2020-07-29 ヘテロ接合性家族性高コレステロール血症（ｈｅＦＨ）を有する患者を処置するための方法 Active JP7104108B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022108732A JP7467538B2 (ja) 2014-07-16 2022-07-06 ヘテロ接合性家族性高コレステロール血症（ｈｅＦＨ）を有する患者を処置するための方法

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201462025362P 2014-07-16 2014-07-16
US62/025,362 2014-07-16
US201462043144P 2014-08-28 2014-08-28
US62/043,144 2014-08-28
US201462080717P 2014-11-17 2014-11-17
US62/080,717 2014-11-17
EP15305419 2015-03-23
EP15305419.2 2015-03-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017502262A Division JP2017528427A (ja) 2014-07-16 2015-07-16 ヘテロ接合性家族性高コレステロール血症（ｈｅＦＨ）を有する患者を処置するための方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022108732A Division JP7467538B2 (ja) 2014-07-16 2022-07-06 ヘテロ接合性家族性高コレステロール血症（ｈｅＦＨ）を有する患者を処置するための方法

Publications (3)

Publication Number Publication Date
JP2020183439A JP2020183439A (ja) 2020-11-12
JP2020183439A5 true JP2020183439A5 (enExample) 2021-01-28
JP7104108B2 JP7104108B2 (ja) 2022-07-20

Family

ID=67107254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020127851A Active JP7104108B2 (ja) 2014-07-16 2020-07-29 ヘテロ接合性家族性高コレステロール血症（ｈｅＦＨ）を有する患者を処置するための方法

Country Status (5)

Country Link
JP (1) JP7104108B2 (enExample)
ES (1) ES2779402T3 (enExample)
IL (1) IL250080B (enExample)
PT (1) PT3169353T (enExample)
ZA (1) ZA201700195B (enExample)

Similar Documents

Publication Publication Date Title
JP2017528427A5 (enExample)
JP2022133396A5 (enExample)
AU2020203636B2 (en) Use of a PCSK9 inhibitor to treat hyperlipidemia
US20230406957A1 (en) Dosing regimens for use with pcsk9 inhibitors
RU2017104800A (ru) Способы лечения пациентов с гетерозиготной семейной гиперхолестеринемией (hefh)
RU2016142277A (ru) Антитела человека к pcsk9 для применения в способах лечения конкретных групп индивидуумов
JP2017506626A5 (enExample)
JP2022141868A (ja) 心血管リスクを低減させる方法
JP2017522316A5 (enExample)
JP2019514907A5 (enExample)
JP2016538248A5 (enExample)
JP2024016218A (ja) リポタンパク質アフェレーシスを受けている高脂血症の患者を治療するための抗ｐｃｓｋ９阻害抗体
TW201306865A (zh) 治療或預防膽固醇相關疾病之方法
JP2013023499A5 (enExample)
JP2011519277A (ja) 中和プロタンパク質コンベルターゼズブチリシンケクシン９型（ｐｃｓｋ９）変形物及びその使用
RU2012110592A (ru) Соединения и способ снижения мочевой кислоты
KR20160115939A (ko) 중등-용량 스타틴 치료법에 의해 적당하게 조절되지 않는 고콜레스테롤혈증이 있는 환자의 치료 방법
RU2017104799A (ru) Способы лечения пациентов с высоким риском возникновения сердечно-сосудистых заболеваний, имеющих гиперхолестеринемию
WO2022032137A1 (en) Methods for treating refractory hypercholesterolemia involving an angptl3 inhibitor
JP2020183439A5 (enExample)
JP2020519658A (ja) 長時間作用性グラチラマー及び脂肪由来幹細胞での多発性硬化症の治療
ES2779126T3 (es) Uso de un inhibidor de PCSK9 para tratar hiperlipidemia
JP2020143156A (ja) 心血管リスクを低減させる方法
JP2020143156A5 (enExample)
Henderson et al. Chronic inflammatory demyelinating polyradiculoneuropathy and severe peripheral oedema: a renal explanation